While the Novavax vaccine study is still ongoing, initial results show it is nearly 96% effective against the older coronavirus and nearly 86% effective against the new variant circulating in the UK.
While the Novavax vaccine study is still ongoing, initial results show it is nearly 96% effective against the older coronavirus and nearly 86% effective against the new variant circulating in the UK.